On the heels of a significant new product introduction for a biotech client, full-service healthcare agency QBFox Healthcomm announced the promotion of three key staffers who drove the launch: Jason Doce, George Abdy and Mark Vespole.
rBIO launched with technology that can reduce the cost of insulin by 30 percent, making U.S. manufacturing cost-effective for insulin and several other drugs.
FCB New York and FDA’s Center for Tobacco Products announced the launch of the next installment of “Little Lungs,” an effective smoking prevention campaign for teens that portrays a set of lungs stunted by teenage smoking.
Remix Therapeutics officially launched with $81 million in financing, with the funds to be used to support the development of the company’s REMaster technology platform while advancing a pipeline of RNA processing targeted therapeutics.
In early October, FCB Health Network proudly launched #WhyVote, a non-partisan campaign that uses the power of storytelling to inspire and empower Americans to vote. On October 30, FCB Health Network partnered with Black Rock Coalition and Club House Global to host the apex of the #WhyVote initiative’s 2020 efforts: #WhyVote Live – A Virtual Pep Rally to the Polls.
Ed Hudson, managing director at Create Health, discusses the increasing importance of brand in pharma – especially in light of increased competition.
Outcome Health announced the launch of Who Saves Me?, a campaign to bring awareness to the overwhelming percentage of physicians who quietly suffer from burnout and mental health struggles.
W2O announced the creation of Hū, the first-of-its kind Patient Activation Organization (PAO).
With $29 million in the company’s pocket, biotech Libra Therapeutics launched to take on neurodegenerative disease, with three pre-clinical programs ready to roll.
Soliton Inc. selected Greater Than One Group as the medical device company’s integrated marketing agency.
